Autism spectrum disorder (ASD) is a developmental disability described by diagnostic
criteria that comprise deficits in social communication and the existence of repetitive …

The social impairments of autism spectrum disorder (ASD) have a major impact on quality of
life, yet there are no medications that effectively treat these core social behavior deficits …

The core symptoms of autism spectrum disorder (ASD) include impaired social
communication, repetitive behaviors, and restricted interests. No effective pharmacotherapy …

Autism spectrum disorder (ASD) is rather common, presenting with prevalent early problems
in social communication and accompanied by repetitive behavior. As vasopressin was …

Scientific naming conventions are often idiosyncratic. For example, biological processes
have acquired names after a physician who described a syndrome (Alois Alzheimer), the …

Vasopressin (also known as arginine vasopressin [AVP]) is a small cyclic peptide that acts at
the V1a, V1b and V2 GPCRs to regulate a wide range of physiological functions, including …

There are no approved pharmacological therapies to address the core symptoms of autism
spectrum disorder (ASD), namely, persistent deficits in social communication and social …

The nonapeptides oxytocin (OXT) and arginine vasopressin (AVP) are two key mediators in
regulating various aspects of mammalian social behaviours. There are several lines of …

Oxytocin (OT) and arginine-vasopressin (AVP) are 2 peptides that are produced in the brain
and released via the pituitary gland to the peripheral blood, where they have diverse …

Oxytocin and vasopressin are peptide hormones secreted from the pituitary that are well
known for their peripheral endocrine effects on childbirth/nursing and blood pressure/urine …